Health information to help you understand symptoms. It isn't a diagnosis.
Check symptoms

Research deep dives

Where dialysis came from

Last reviewed November 17, 2026. OwieClear editorial team. Waiting for clinician review. Not medical advice. Talk with your doctor about your own care.

Kidney failure was uniformly fatal within living memory. The machine that changed that was built in occupied Holland from cellophane sausage casing, wooden slats and parts of a washing machine.

Making it a treatment rather than a one-off rescue took another fifteen years and a small plastic tube, and deciding who got it produced one of the founding controversies of medical ethics.

Related pages: Chronic kidney disease

The bottom line

What we know
  • Willem Kolff built the first working artificial kidney in the Netherlands during the Second World War.
  • His first fifteen patients died; the sixteenth, in 1945, survived.
  • The Scribner shunt in 1960 made repeated long-term dialysis possible.
  • A Seattle committee selecting patients for scarce dialysis became a landmark in bioethics.
  • The United States made kidney failure treatment a Medicare entitlement in 1972.
What is still open
  • How much the 1972 entitlement shaped later United States health policy.
  • Why home dialysis rates fell so sharply after the entitlement.

The story, step by step

  1. 1. The machine ()
  2. 2. The shunt ()
  3. 3. The committee ()
  4. 4. The entitlement ()
What the evidence labels mean
GuidelineAn official recommendation from an expert group after weighing all the evidence.
Review of many studiesCombines the results of many studies (a systematic review or meta-analysis).
Randomized trialPeople were randomly given a treatment or a comparison, the best way to test cause and effect.
Large observational studyFollows many people over time. Shows strong links, but not always cause and effect.
Small or early studyA small study, case series, or first results. Needs to be confirmed.
Lab or animal studyDone in cells or animals. May not apply to people.
Part 1 of 4

Kolff's rotating drum

Small or early study

What happens

Built under occupation, from scraps.

What the research shows

  • Willem Kolff, a young Dutch physician, was moved by watching a patient die slowly of kidney failure and set out to build a machine to clean blood.
  • He wound cellophane tubing, of the kind used for sausage casing, around a wooden drum that rotated in a bath of fluid. Blood inside the tubing exchanged waste across the cellophane.
  • He built it during the German occupation, using an enamel tank and parts from a washing machine, with materials that were very difficult to obtain.
  • His first fifteen patients died. In 1945 the sixteenth, a woman with acute kidney failure, recovered and lived for several more years.
  • After the war he gave machines away to centres in other countries rather than patenting the design.
  • The technique worked for acute kidney failure, where the kidneys might recover, because each treatment required cutting down to a new artery and vein.

Why it matters

The fundamental problem was not the machine. It was that access to the bloodstream could only be gained a limited number of times before the vessels ran out.

What's still uncertain

  • How many of the early failures were technique rather than patient selection.

Read more

Next: The shunt

Part 2 of 4

The small tube that changed everything

Small or early study

What happens

Teflon, 1960, Seattle.

What the research shows

  • Belding Scribner, in Seattle, realised that if a permanent connection between an artery and a vein could be left in place, dialysis could be repeated indefinitely.
  • The solution used Teflon, a newly available material that blood did not readily clot against, to form a loop outside the skin connecting the two vessels.
  • The first patient treated with it in 1960 lived for many years, having been expected to die within weeks.
  • Chronic kidney failure became a treatable condition rather than a terminal diagnosis, essentially overnight.
  • The surgically created arteriovenous fistula, developed later in the 1960s, superseded the external shunt and remains the preferred access today.
  • Scribner, like Kolff, did not patent the device.

Why it matters

A material science advance, not a medical one, converted a rescue procedure into a long-term therapy.

What's still uncertain

  • Why fistula creation took several more years to become standard.

Read more

Next: The committee

Part 3 of 4

Deciding who lived

Small or early study

What happens

The founding case of modern bioethics.

What the research shows

  • Seattle had far more patients needing dialysis than machines, and a committee of lay members was convened to choose between medically eligible candidates.
  • Having excluded medical factors, the committee considered things like employment, marital status, church attendance, dependants and perceived social worth.
  • A 1962 magazine article describing the process caused a national controversy, and the group became known as the God committee.
  • The criticism was that it rewarded conventional middle-class respectability and disadvantaged those who did not fit it.
  • The episode is widely credited with catalysing the development of bioethics as a field, and with shaping later thinking on allocating scarce medical resources.
  • It remains the reference case in arguments about transplant allocation today.

Why it matters

The committee was created because the alternative was for doctors to make the same decisions privately and without scrutiny. Making the choice visible is what made it intolerable.

What's still uncertain

  • How much the controversy directly drove the 1972 legislation.

Read more

Next: The entitlement

Part 4 of 4

1972, and what followed

Small or early study

What happens

A unique piece of United States policy.

What the research shows

  • In 1972 the United States Congress extended Medicare to cover treatment for end-stage kidney disease, regardless of the patient's age.
  • It remains the only disease-specific entitlement of its kind in the United States, covering dialysis and transplantation for essentially everyone who needs them.
  • The decision followed public testimony that included a patient being dialysed in front of a congressional committee.
  • Costs far exceeded projections, as the number of people treated grew enormously beyond the original estimates.
  • The program also shifted care toward in-centre haemodialysis, and home dialysis rates, which had been higher before, fell substantially.
  • Later policy has tried to reverse that, promoting home dialysis and pre-emptive transplantation.

Why it matters

The 1972 decision solved the allocation problem by removing the scarcity, and in doing so created the economic structure that still shapes how dialysis is delivered.

What's still uncertain

  • How much the payment structure drove the shift away from home dialysis.

Read more

More plain-language reading

See something wrong or unclear on this page? Suggest a correction. OwieClear is for education only and isn't medical advice.